Cannabis Reg. Update: NY Cannabis Advisory Meets, Vermont Supports Drug Decriminalization, New Medical Cannabis Bill San Francisco

Good News In New York: First Meeting Of NY Cannabis Advisory Board and First Legal Marijuana Harvest

On June 30, the New York Cannabis Advisory Board, which will decide how the state spends tax revenue from the marijuana industry, held its inaugural meeting. Addressed by Chris Alexander, the executive director of the Office of Cannabis Management, told the advisory board members that under the Marijuana Regulation and Taxation Act, they are primarily responsible for distributing money to the New York State Community Grants Reinvestment Fund.

“We’re working to create the most equitable and inclusive industry in the nation,” Alexander said. “We are moving forward full steam ahead.”

The NY Cannabis Insider conference schedule is now available. In September, a "Syracuse Half-Day Conference" cannabis business conference will be held on the Rail Line, Syracuse, NY.

New York highlighted its first legal recreational cannabis growers, who received their cultivation licenses last April.

"New York's move is a potential lifeline for farmers growing CBD during a price slump," the AP reported. "They have the opportunity to make a lot more money growing what is essentially the same plant, but with higher levels of THC, the compound that makes people feel high."

Vermont Poll: Majority Of Voters Support Decriminalizing Drug Possession & Increasing Access to Health Services

New polling data, released by Data for Progress and the Drug Policy Alliance (DPA), showed that more than four in five (84%) Vermont voters support eliminating criminal penalties for possession of small amounts of drugs. Additionally, the poll found that 81% of voters support reframing the state's approach to drug use as a health issue with a focus on reducing the harms of addiction and providing health and recovery services.

“With Vermont having one of the highest increases in overdoses in the country last year, it’s clear that the existing approach of criminalizing people who use drugs isn’t working to keep people safe. In fact, it has only made things worse,” said Grey Gardner, senior staff attorney for the Drug Policy Alliance

California: New Bill to Avoid Prohibition of Medical Cannabis heads to the Assembly Appropriations Committee

Senate Bill 1186, headed by Scott Wiener (D-San Francisco), which requires cities to allow patients access to purchase legal medicinal cannabis by delivery, passed the Assembly Judiciary Committee. Now heads to the Assembly Appropriations Committee.

"Cannabis is an important and life-saving medicine for many people, including those who have cancer, HIV/AIDS, chronic pain, arthritis, neurodegenerative disorders, and numerous other illnesses. Everyone deserves access to medicine," reads the bill.

“Seniors, those living with HIV and chronic illnesses, and disabled people need access to medical cannabis,” said Senator Wiener, “SB 1186 will ensure we aren’t abandoning people and will allow cannabis access across the state.”

SB 1186 is sponsored by the California Cannabis Industry Association and  community organizations, including the San Francisco AIDS Foundation and California NORML.

Image by El Planteo

 

Posted In: Assembly Appropriations CommitteeAssociated PressCalifornia NORMLChris AlexanderData for ProgressDrug Policy AllianceDrug Policy Alliance (DPA)Grey GardnerMarijuana Regulation and Taxation ActNew York Cannabis Advisory BoardNew York State Community Grants Reinvestment FundOffice of Cannabis ManagementSan Francisco AIDS FoundationScott WienerThe California Cannabis Industry AssociationCannabisGovernmentRegulationsPoliticsMarketsGeneral

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.